EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches

Runkai Zhou iD, Fazhi Wang, Jiazhe Wen, Xuefeng Zhou, Yugang Wen

Cancer Medicine · 2025-09 · 14 (17)

DOI: 10.1002/cam4.71185 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Medicine, online erschienen am 30.08.2025. Verfasst von Runkai Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Glucose. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer (CRC) is one of the most common malignant tumors, and its morbidity ranks third among all cancers, with a trend toward younger patients. Metabolic reprogramming, a unique metabolic mode in tumor cells, is closely related to the occurrence and development of CRC. Numerous studies have confirmed that many genetic and protein changes can regulate cellular metabolic reprogramming, of which changes in glucose metabolism have the greatest impact. These aberrant metabolic processes provide energy and essential nutrients to CRC cells, promoting their proliferation and metastasis and influencing tumor resistance. The purpose of this review is to outline the role of glucose metabolic reprogramming in the onset and development of CRC, discuss the research progress in the dual reprogramming of glucose metabolism and lipid metabolism or glucose metabolism and amino acid metabolism, and address the issues of targeted metabolism therapy and drug resistance.

Methods

We searched PubMed for review articles published in English between January 1, 2015, and April 26, 2024, which included “Colorectal Neoplasms” with “Metabolic Reprogramming” OR “Glucose Metabolism Disorders” OR “The Warburg Effect” OR “Targeted Therapy.” Subsequently, the literature was classified, organized, and summarized. Various types of studies were integrated and compiled into this review. Additionally, mechanism diagrams were drawn to facilitate the understanding of this study. The figures were created using BioRender.com and has obtained the official publication license.

Conclusions

Glucose metabolic reprogramming serves as a pivotal driver of CRC initiation, progression, and chemoresistance, while its crosstalk with lipid or amino acid metabolic reprogramming further amplifies the malignant phenotype of CRC. Targeted therapeutic strategies aiming at glucose metabolic reprogramming (such as metabolic inhibitors, combination with immunotherapy) and related clinical research have demonstrated potential for inhibiting CRC progression and improving treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsGlucoseHumansMolecular Targeted TherapyLipid MetabolismCellular ReprogrammingWarburg Effect, OncologicAnimalsDrug Resistance, NeoplasmMetabolic Reprogramming

Stichwörter der Autor:innen

colorectal cancerglucose metabolismmetabolic reprogrammingtargeted therapy

Substanzen

Glucose

Autor:innen und Institutionen

  • Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Department of Oncology, The Dongtai Hospital of Nantong University, Dongtai, Jiangsu, China.

ORCID-Profile: Runkai Zhou

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhou, R., Wang, F., Wen, J., Zhou, X., & Wen, Y. (2025). Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches. Cancer Medicine, 14(17). https://doi.org/10.1002/cam4.71185

Vancouver

Zhou R, Wang F, Wen J, Zhou X, Wen Y. Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches. Cancer Medicine. 2025;14(17). doi:10.1002/cam4.71185

BibTeX
@article{Zhou2025,
  author = {Zhou, Runkai and Wang, Fazhi and Wen, Jiazhe and Zhou, Xuefeng and Wen, Yugang},
  title = {Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches},
  journal = {Cancer Medicine},
  year = {2025},
  volume = {14},
  number = {17},
  doi = {10.1002/cam4.71185}
}
Kostenlos starten →